ID
14240
Beschrijving
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00180011
Link
https://clinicaltrials.gov/show/NCT00180011
Trefwoorden
Versies (1)
- 05-04-16 05-04-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
5 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Asthma NCT00180011
Eligibility Asthma NCT00180011
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
smoking history
Datatype
boolean
Alias
- UMLS CUI [1]
- C1519384
- UMLS CUI [2]
- C3241966
- UMLS CUI [3]
- C1277691
Beschrijving
women of childbearing age must be using effective contraception
Datatype
boolean
Alias
- UMLS CUI [1]
- C1960468
- UMLS CUI [2]
- C0700589
Beschrijving
malignancy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0006826
- UMLS CUI [1,2]
- C0040223
Beschrijving
lung disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0024115
Beschrijving
inability to comply with study protocol
Datatype
boolean
Alias
- UMLS CUI [1]
- C1321605
Similar models
Eligibility Asthma NCT00180011
- StudyEvent: Eligibility
C0030705 (UMLS CUI [1,2])
C2229760 (UMLS CUI [2])
C0082607 (UMLS CUI [2])
C4039704 (UMLS CUI [3])
C3241966 (UMLS CUI [2])
C1277691 (UMLS CUI [3])
C0700589 (UMLS CUI [2])
C0040223 (UMLS CUI [1,2])